Erythromycin as a prokinetic agent in newborns--useful or doubtful. Commentary on Y. Mansi et al.: Randomized controlled trial of a high dose of oral erythromycin for the treatment of feeding intolerance in preterm infants (Neonatology 2011;100:290-294).

Pak C Ng

Journal: Neonatology 2012;100(3):297-8

PMID: 21701224

Abstract

Address: Department of Paediatrics, Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, NT, SAR, China. [email protected]

Link outs

Subscription / membership required

Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.